{"id":"bretylium","rwe":[],"tags":[{"label":"bretylium","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Beta-1 adrenergic receptor","category":"target"},{"label":"ADRB1","category":"gene"},{"label":"ADRB2","category":"gene"},{"label":"SLC6A2","category":"gene"},{"label":"C01BD02","category":"atc"},{"label":"Off-Patent","category":"patent"},{"label":"Generic Available","category":"availability"},{"label":"Established","category":"status"},{"label":"Life-Threatening Ventricular Tachycardia","category":"indication"},{"label":"Prevention of Ventricular Fibrillation","category":"indication"},{"label":"Ventricular arrhythmia","category":"indication"},{"label":"Ventricular fibrillation","category":"indication"},{"label":"Hospira","category":"company"},{"label":"Approved 1980s","category":"decade"},{"label":"Adrenergic Agents","category":"pharmacology"},{"label":"Adrenergic Antagonists","category":"pharmacology"},{"label":"Anti-Arrhythmia Agents","category":"pharmacology"},{"label":"Antihypertensive Agents","category":"pharmacology"},{"label":"Cardiovascular Agents","category":"pharmacology"},{"label":"Neurotransmitter Agents","category":"pharmacology"}],"phase":"marketed","safety":{"drugInteractions":[{"url":"/drug/ciprofloxacin","drug":"ciprofloxacin","action":"Monitor closely","effect":"May interact with Ciprofloxacin","source":"DrugCentral","drugSlug":"ciprofloxacin"},{"url":"/drug/erythromycin","drug":"erythromycin","action":"Monitor closely","effect":"May interact with Erythromycin","source":"DrugCentral","drugSlug":"erythromycin"},{"url":"/drug/gatifloxacin","drug":"gatifloxacin","action":"Avoid combination","effect":"May interact with Gatifloxacin","source":"DrugCentral","drugSlug":"gatifloxacin"},{"url":"/drug/gemifloxacin","drug":"gemifloxacin","action":"Avoid combination","effect":"May interact with Gemifloxacin","source":"DrugCentral","drugSlug":"gemifloxacin"},{"url":"/drug/levofloxacin","drug":"levofloxacin","action":"Avoid combination","effect":"May interact with Levofloxacin","source":"DrugCentral","drugSlug":"levofloxacin"},{"url":"/drug/lomefloxacin","drug":"lomefloxacin","action":"Avoid combination","effect":"May interact with Lomefloxacin","source":"DrugCentral","drugSlug":"lomefloxacin"},{"url":"/drug/moxifloxacin","drug":"moxifloxacin","action":"Avoid combination","effect":"May interact with Moxifloxacin","source":"DrugCentral","drugSlug":"moxifloxacin"},{"url":"/drug/nalidixic-acid","drug":"nalidixic acid","action":"Avoid combination","effect":"May interact with Nalidixic Acid","source":"DrugCentral","drugSlug":"nalidixic-acid"},{"url":"/drug/norfloxacin","drug":"norfloxacin","action":"Avoid combination","effect":"May interact with Norfloxacin","source":"DrugCentral","drugSlug":"norfloxacin"},{"url":"/drug/ofloxacin","drug":"ofloxacin","action":"Avoid combination","effect":"May interact with Ofloxacin","source":"DrugCentral","drugSlug":"ofloxacin"},{"url":"/drug/vardenafil","drug":"vardenafil","action":"Monitor closely","effect":"May interact with Vardenafil","source":"DrugCentral","drugSlug":"vardenafil"}],"contraindications":["Aortic valve stenosis","Kidney disease","Low cardiac output syndrome","Orthostatic hypotension","Pulmonary hypertension","Sinus bradycardia"]},"trials":[],"aliases":[],"company":"Pfizer","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=BRETYLIUM","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:22:39.517131+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:22:46.995816+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=BRETYLIUM","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:22:47.310784+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1199080/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:22:48.022587+00:00"}},"allNames":"bretylium tosylate","offLabel":[],"synonyms":["bretylium","bretylium tosilate","bretylan","bretylate","bretylium tosylate"],"timeline":[{"date":"1986-01-01","type":"neutral","source":"FDA Orange Book","milestone":"Rights transferred from INTL MEDICATION to Hospira"},{"date":"1986-03-06","type":"positive","source":"DrugCentral","milestone":"FDA approval (Intl Medication)"},{"date":"1986-04-29","type":"positive","source":"FDA Orange Book","milestone":"Bretylium Tosylate approved — 50MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**"},{"date":"1989-04-12","type":"positive","source":"FDA Orange Book","milestone":"Bretylium Tosylate In Dextrose 5% In Plastic Container approved — 200MG/100ML"}],"brandName":"Bretylium Tosylate","ecosystem":[{"indication":"Life-Threatening Ventricular Tachycardia","otherDrugs":[{"name":"amiodarone","slug":"amiodarone","company":"Wyeth Pharms Inc"},{"name":"flecainide","slug":"flecainide","company":""},{"name":"procainamide","slug":"procainamide","company":""},{"name":"procaine","slug":"procaine","company":"Lederle"}],"globalPrevalence":null},{"indication":"Prevention of Ventricular Fibrillation","otherDrugs":[{"name":"amiodarone","slug":"amiodarone","company":"Wyeth Pharms Inc"}],"globalPrevalence":null},{"indication":"Ventricular arrhythmia","otherDrugs":[{"name":"disopyramide","slug":"disopyramide","company":"Gd Searle Llc"},{"name":"lidocaine","slug":"lidocaine","company":"Fresenius Kabi Usa"},{"name":"mexiletine","slug":"mexiletine","company":""},{"name":"moracizine","slug":"moracizine","company":""}],"globalPrevalence":null},{"indication":"Ventricular fibrillation","otherDrugs":[{"name":"amiodarone","slug":"amiodarone","company":"Wyeth Pharms Inc"}],"globalPrevalence":null}],"mechanism":{"target":"Beta-1 adrenergic receptor","novelty":"Follow-on","targets":[{"gene":"ADRB1","source":"DrugCentral","target":"Beta-1 adrenergic receptor","protein":"Beta-1 adrenergic receptor"},{"gene":"ADRB2","source":"DrugCentral","target":"Beta-2 adrenergic receptor","protein":"Beta-2 adrenergic receptor"},{"gene":"SLC6A2","source":"DrugCentral","target":"Sodium-dependent noradrenaline transporter","protein":"Sodium-dependent noradrenaline transporter"}],"modality":"Small Molecule","drugClass":"bretylium","explanation":"","oneSentence":"","technicalDetail":"Bretylium Tosylate acts as a presynaptic adrenergic neuron blocker, inhibiting the release of norepinephrine from sympathetic nerve terminals, which in turn reduces the incidence of ventricular arrhythmias."},"commercial":{"launchDate":"1986","_launchSource":"DrugCentral (FDA 1986-03-06, INTL MEDICATION)"},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/394","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=BRETYLIUM","fields":["publications"],"source":"PubMed/NCBI"},{"id":3,"url":"https://www.fda.gov/drugs/drug-approvals-and-databases/orange-book-data-files","fields":["patents","exclusivity","genericManufacturers"],"source":"FDA Orange Book"}],"_enrichedAt":"2026-03-30T09:02:04.573591","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:22:49.808068+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"amiodarone","drugSlug":"amiodarone","fdaApproval":"1985-12-24","patentExpiry":"Mar 13, 2029","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"dofetilide","drugSlug":"dofetilide","fdaApproval":"1999-10-01","genericCount":13,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"ibutilide","drugSlug":"ibutilide","fdaApproval":"1995-12-28","genericCount":4,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"dronedarone","drugSlug":"dronedarone","fdaApproval":"2009-07-01","patentExpiry":"Jun 30, 2031","patentStatus":"Patent protected","relationship":"same-class"}],"genericName":"bretylium","indications":{"approved":[{"name":"Life-Threatening Ventricular Tachycardia","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Prevention of Ventricular Fibrillation","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Ventricular arrhythmia","source":"DrugCentral","snomedId":44103008,"regulator":"FDA"},{"name":"Ventricular fibrillation","source":"DrugCentral","snomedId":71908006,"regulator":"FDA"}],"offLabel":[{"name":"Cardiac arrest","source":"DrugCentral","drugName":"BRETYLIUM","evidenceCount":57,"evidenceLevel":"strong"}],"pipeline":[]},"currentOwner":"Hospira","drugCategory":"established","labelChanges":[],"patentStatus":"Off-patent — no active Orange Book patents","relatedDrugs":[{"drugId":"amiodarone","brandName":"amiodarone","genericName":"amiodarone","approvalYear":"1985","relationship":"same-class"},{"drugId":"dofetilide","brandName":"dofetilide","genericName":"dofetilide","approvalYear":"1999","relationship":"same-class"},{"drugId":"ibutilide","brandName":"ibutilide","genericName":"ibutilide","approvalYear":"1995","relationship":"same-class"},{"drugId":"dronedarone","brandName":"dronedarone","genericName":"dronedarone","approvalYear":"2009","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"_patentsChecked":true,"crossReferences":{"NUI":"N0000171583","MMSL":"3352","NDDF":"001840","UNII":"RZR75EQ2KJ","VUID":"4019638","VANDF":"4018742","INN_ID":"927","RXNORM":"151447","UMLSCUI":"C0006168","chemblId":"CHEMBL1199080","ChEMBL_ID":"CHEMBL1199080","KEGG_DRUG":"D00645","DRUGBANK_ID":"DB01158","PUBCHEM_CID":"2431","SNOMEDCT_US":"372774002","IUPHAR_LIGAND_ID":"7130","SECONDARY_CAS_RN":"59-41-6","MESH_DESCRIPTOR_UI":"D001950","MESH_SUPPLEMENTAL_RECORD_UI":"C045166"},"formularyStatus":[],"_enricherVersion":"v2","_offLabelChecked":true,"developmentCodes":[],"ownershipHistory":[{"period":"1986-","companyName":"Intl Medication","relationship":"Original Developer"},{"period":"present","companyName":"Pfizer","relationship":"Current Owner"}],"pharmacokinetics":{"source":"DrugCentral","bioavailability":"23%"},"publicationCount":1110,"therapeuticAreas":["Neuroscience"],"atcClassification":{"source":"DrugCentral","atcCode":"C01BD02","allCodes":["C01BD02"]},"biosimilarFilings":[],"originalDeveloper":"Intl Medication","recentPublications":[],"companionDiagnostics":[],"genericManufacturers":6,"_genericFilersChecked":true,"genericManufacturerList":["Abraxis Pharm","Astrazeneca","Breckenridge","Hikma","Intl Medication","Luitpold"],"status":"approved","companyName":"Hospira","companyId":"pfizer","modality":"Small molecule","firstApprovalDate":"1986","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:22:49.808068+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":false,"score":1}}